News about Global Pharma

ZEISS Gets FDA Clearance for INTRABEAM 700

ZEISS Medical Technology is dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT).

Global Pharma | 09/04/2025 | By Manvi |  222

AmacaThera, Global Pharma Giant Team Up to Create Advanced Long-Acting Biologic Using AmacaGel

Through this partnership, a single-injection, long-acting biologic will be developed using AmacaThera's advanced hydrogel delivery platform, AmacaGel™, in combination with the partner's therapeutic. <br />

Global Pharma | 09/04/2025 | By Abha |  249

Korean Ministry Grants Approval to GC Biopharma's BARYTHRAX Anthrax Vaccine

With the approval by MFDS, BARYTHRAX has become Korea's 39th novel drug.

Global Pharma | 09/04/2025 | By Abha |  271

Volta Medical Appoints Bill Hoffman as Executive Chairman of Board of Directors

Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, announced the appointment of Bill Hoffman as Executive Chairman of its Board of Directors.

Global Pharma | 08/04/2025 | By Manvi |  269

Innocan Pharma Files Divisional Patent in China for Liposome-based CBD Technology

Innocan Pharma has filed a divisional patent application in China for its liposome-based CBD delivery technology, marking a strategic move to expand its IP footprint in Asia’s rapidly growing pharmaceutical market.

Global Pharma | 08/04/2025 | By Manvi |  247

Stramsen Biotech Secures USD 25 Million Funding Commitment from GEM Global Yield LLC SCS

Stramsen Biotech Inc., a plant-based biopharmaceutical company, has secured USD 25 million in funding from GEM Global Yield LLC SCS to support its clinical development, global expansion, and the path toward a public listing.

Global Pharma | 08/04/2025 | By Manvi |  349

Ventris Medical Receives FDA 510(k) Clearance for Backpack Biologic Scaffold in Spinal Fusion Procedures

Ventris Medical announced that the United States Food and Drug Administration has granted 510(k) clearance for Backpack® (Porous Biologic Scaffold, K250556) for use in the Intervertebral Disc Space.

Global Pharma | 08/04/2025 | By Manvi |  150

4Moving Biotech Secures EUR 7.6M France 2030 Grant to Advance Osteoarthritis Drug

4MB's selection is a significant endorsement, granted through a rigorous, multi-stage evaluation process by leading scientific, clinical, and technological experts.

Global Pharma | 08/04/2025 | By Abha |  250

Dr JB Sharma Appointed as Head of Obstetrics & Gynaecology at Yashoda Medicity

Dr. J.B. Sharma is well-recognised for his work in Obstetrics and Gynaecology. He is in the top 2 percent of leading doctors in the world as per Stanford University.

Global Pharma | 08/04/2025 | By Abha |  764

ICU Medical Receives FDA Clearance for Plum Solo IV Pump, Expanding IV Performance Platform

ICU Medical Inc. has announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo™ precision IV pump, a single-channel complement to the dual-channel Plum Duo™.

Global Pharma | 07/04/2025 | By Manvi |  280